NATIONAL BANK OF CANADA /FI/ - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 152 filers reported holding IMMUNITYBIO INC in Q1 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$1,069,929
-50.9%
699,300
-12.1%
0.00%
-50.0%
Q2 2023$2,179,396
+806.6%
795,400
+502.1%
0.00%
+300.0%
Q1 2023$240,404
-64.1%
132,1000.0%0.00%
-50.0%
Q4 2022$669,711
+7341.2%
132,100
+7238.9%
0.00%
Q3 2022$9,000
+28.6%
1,8000.0%0.00%
Q2 2022$7,000
-30.0%
1,8000.0%0.00%
Q1 2022$10,000
-9.1%
1,8000.0%0.00%
Q4 2021$11,0001,8000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders